logo-loader
RNS
Johnson Matthey PLC

Johnson Matthey PLC - Completion of Diagnostic Services sale

RNS Number : 2615O
Johnson Matthey PLC
02 October 2023
 

2nd October 2023

 

Johnson Matthey Plc

(the Company)


Johnson Matthey announces completion of Diagnostic Services (also known as Tracerco) sale

 

Further to the announcement on 3rd May 2023, Johnson Matthey Plc (JM) is pleased to announce that it has completed the sale of its Diagnostic Services business on 29th September 2023 in accordance with the terms of the sale agreement entered into between JM and Sullivan Street Partners for a consideration of £55 million.

 

 

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, we improve the performance, function and safety of our customers' products. Our science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 15,000 Johnson Matthey professionals collaborate with our network of customers and partners to make a real difference to the world around us. For more information, visit www.matthey.com

 

 

ENDS

 

Enquiries: 

 



Investor Relations

Martin Dunwoodie

Louise Curran

Carla Fabiano

 

Director of Investor Relations

Senior Investor Relations Manager

Senior Investor Relations Manager

 

020 7269 8241

020 7269 8235

020 7269 8004

 

Media

Harry Cameron

 

 

Teneo

 

 

020 7353 4200

 

 



 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774
Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGZMGGFMKGFZM
NO INVESTMENT ADVICE

This content is published by Proactive Investors Limited and made available subject to the terms and conditions of use of its website (see Terms of Use).

Proactive Investors is a full-service financial newswire. We produce independent, objective financial journalism and do not provide personalised investment advice, act as a broker, or recommend specific securities to individual investors.

Financial content published on this Site is produced under the journalist exemption provided for in Article 20 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, and in accordance with FCA guidance at PERG 8.12. Where a communication is not otherwise exempt, it is issued or approved for distribution in the UK by Proactive Investors Limited.

All information used in the preparation of this communication has been compiled from publicly available sources that we believe to be reliable, however, we cannot, and do not, guarantee the accuracy or completeness of this communication.

This communication is intended for information purposes only and does not constitute investment advice, a personal recommendation, an offer, solicitation, or inducement to buy or sell any investment or financial product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

This communication has been prepared without taking account of the objectives, financial situation or needs of any particular investor. Before entering into any transaction, investors should consider suitability for their individual circumstances and should read the relevant prospectus, term sheet, subscription agreement, information memorandum, prospectus or other offering document in full.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise, and you may not recover the amount you invest.

This communication may contain information obtained from third parties, including credit ratings and financial data. Reproduction and distribution of third-party content in any form is prohibited except with the prior written consent of the relevant third party. Credit ratings are statements of opinion and should not be relied upon as investment advice.

FOR OUR FULL DISCLAIMER CLICK HERE

Directorate change

15 hours, 40 minutes ago

Johnson Matthey half year results

15 hours, 41 minutes ago

Transaction in Own Shares

3 days, 12 hours ago

Director/PDMR Shareholding

1 week, 1 day ago

Director Declaration

1 week, 1 day ago

Transaction in Own Shares

1 week, 3 days ago

Total Voting Rights

2 weeks, 3 days ago

Transaction in Own Shares

2 weeks, 3 days ago

2 min read